KernDG, FrumkinH. Asthma in respiratory therapists. Ann Intern Med, 1989; 110(10):767–773.
2.
ChristianiDC, KernDG. Asthma risk and occupation as a respiratory therapist. Am Rev Respir Dis, 1993; 148(3):671–674.
3.
Dimich-WardH, WymerML, Chan-YeungM. Respiratory health survey of respiratory therapists. Chest, 2004; 126(4):1048–1053.
4.
DelclosGL, GimenoD, ArifAA, BurauKD, CarsonA, LuskC, et al. Occupational risk factors and asthma among health care professionals. Am J Respir Crit Care Med, 2007; 175(7):667–675.
5.
YuIT, LiY, WongTW, TamW, ChanAT, LeeJH, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med, 2004; 350(17):1731–1739.
6.
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. DawoodFS, JainS, FinelliL, ShawMW, LindstromS, GartenRJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med, 2009; 360(25):2605–2615. Erratum in: N Engl J Med 2009;361(1):102..
7.
GraltonJ, ToveyE, McLawsML, RawlinsonWD. The role of particle size in aerosolised pathogen transmission: a review. J Infect, 2011; 62(1):1–13.
8.
KacmarekRM, KratohvilJ. Evaluation of a double-enclosure double-vacuum unit scavenging system for ribavirin administration. Respir Care, 1992; 37(1):37–45.
9.
DemersRR, ParkerJ, FrankelLR, SmithDW. Administration of ribavirin to neonatal and pediatric patients during mechanical ventilation. Respir Care, 1986; 31(12):1188–1196.
10.
FallatRJ, KandalK. Aerosol exhaust: escape of aerosolized medication into the patient and caregiver's environment. Respir Care, 1991; 36(9):1008–1016.
11.
McKeownSI, SerrequiN. Modification of a high frequency oscillator circuit with a heated expiratory filter to prevent infectious pathogen transmission: a bench study. Respir Care, 2012; 57(4):531–536.
12.
FinkJB. Device and equipment evaluations. Respir Care, 2004; 49(10):1157–1164.
13.
SomogyiR, VeselyAE, AzamiT, PreissD, FisherJ, CorreiaJ, FowlerRA. Disperal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory distress syndrome. Chest, 2004; 125(3):1155–1157.
14.
HuiDS, ChowBK, ChuLCY, NgSS, HallSD, GinT, ChanMTV. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest, 2009; 135(3):648–654.
15.
SimondsAK, HanakA, ChatwinM, MorrellMJ, HallA, ParkerKH, et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess, 2010; 14(46):131–172.
